MFS
TXMD icon

MSI Financial Services’s TherapeuticsMD TXMD Stock Holding History

MSI Financial Services’s Portfolio TXMD Stock Details TXMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$6K Buy
20
+5
+33% +$1.55K ﹤0.01% 3084
2016
Q3 		$5K Hold
15
– – ﹤0.01% 3158
2016
Q2 		$6K Hold
15
– – ﹤0.01% 3066
2016
Q1 		$5K Hold
15
– – ﹤0.01% 3180
2015
Q4 		$8K Buy
+15
New +$5.54K ﹤0.01% 2844

Other funds holding TXMD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

MSI Financial Services's TXMD Position: Q4 2016 in Review

MSI Financial Services increased its TherapeuticsMD (TXMD) stake by 33% in Q4 2016, buying an estimated $1.55K and bringing the position to 20 shares worth $6K. The position accounts for ﹤0.01% of the portfolio, ranked #3084.

MSI Financial Services first reported a position in TXMD in Q4 2015 and has held it in 5 quarters since. The position peaked at $8K in Q4 2015. 146 funds tracked by Wall St. Rank hold TXMD as of Q4 2016.

  • MSI Financial Services held 20 shares of TherapeuticsMD worth $6K as of Q4 2016.
  • MSI Financial Services bought 5 TherapeuticsMD shares in Q4 2016, an estimated $1.55K.
  • TherapeuticsMD made up ﹤0.01% of MSI Financial Services's portfolio in Q4 2016, its #3084 holding.
  • MSI Financial Services first reported a position in TherapeuticsMD in Q4 2015 and has held it in 5 quarters since.
  • MSI Financial Services's TherapeuticsMD position peaked at $8K in Q4 2015.
  • 146 funds tracked by Wall St. Rank held TherapeuticsMD as of Q4 2016.

Based on MSI Financial Services's 13F filing for Q4 2016, filed 13 Jan 2017.